44,963 Shares in Mirion Technologies, Inc. $MIR Acquired by Federated Hermes Inc.

Federated Hermes Inc. acquired a new position in shares of Mirion Technologies, Inc. (NYSE:MIR) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 44,963 shares of the company’s stock, valued at approximately $1,046,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Royal Bank of Canada boosted its holdings in shares of Mirion Technologies by 258.2% during the first quarter. Royal Bank of Canada now owns 98,828 shares of the company’s stock valued at $1,433,000 after acquiring an additional 71,241 shares during the period. AQR Capital Management LLC lifted its position in Mirion Technologies by 124.3% in the 1st quarter. AQR Capital Management LLC now owns 199,211 shares of the company’s stock valued at $2,889,000 after purchasing an additional 110,399 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Mirion Technologies by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 122,962 shares of the company’s stock valued at $1,783,000 after purchasing an additional 5,366 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Mirion Technologies by 8.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 434,583 shares of the company’s stock worth $6,301,000 after purchasing an additional 34,973 shares during the last quarter. Finally, Janney Montgomery Scott LLC bought a new position in Mirion Technologies in the 2nd quarter worth about $483,000. 78.51% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Mirion Technologies

In related news, Director Lawrence D. Kingsley sold 350,000 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $24.73, for a total transaction of $8,655,500.00. Following the completion of the transaction, the director owned 3,509,075 shares of the company’s stock, valued at $86,779,424.75. This trade represents a 9.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 6.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Evercore ISI began coverage on Mirion Technologies in a report on Tuesday, November 25th. They set an “outperform” rating and a $29.00 price target on the stock. Morgan Stanley started coverage on Mirion Technologies in a research report on Friday, January 23rd. They issued an “equal weight” rating and a $29.00 target price on the stock. JPMorgan Chase & Co. boosted their price target on Mirion Technologies from $28.00 to $34.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Finally, Citigroup decreased their price target on Mirion Technologies from $35.00 to $33.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $28.38.

Mirion Technologies Stock Performance

MIR opened at $23.25 on Friday. The business has a 50 day moving average price of $24.98 and a two-hundred day moving average price of $23.90. The company has a debt-to-equity ratio of 0.63, a current ratio of 4.83 and a quick ratio of 4.32. The company has a market capitalization of $5.90 billion, a price-to-earnings ratio of 211.42 and a beta of 0.97. Mirion Technologies, Inc. has a 1-year low of $12.00 and a 1-year high of $30.28.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.